[Whole-body retention studies of 167Tm-citrate.--Estimation of radiation dose to human from 167Tm-citrate--(author's transl)].
For the purpose of calculating absorbed dose to humans from 167Tm-citrate, the whole-body retention studies using 5 rats were carried out. Up to 40 days following intravenous injection of 167Tm-citrate, the whole-body counts were monitored with a animal counter. The whole-body retention curve was obtained with three exponentaial components. Namely, the 26% of the injected 167 Tm-citrate had a biological half-time of 3.4 hours, 12.5% had a biological half-time of 99 hours and 61.5% had a biological half-time of 106 days. These results indicate, that three components consist of the rapid clearance from the kidneys, the retention in the liver and other soft tissues with relatively long half-time and the retention in the bones with long half-time. Based on these biological data and the MIRD Committee method, the average dose estimates to the bone and whole-body from intravenous administration of 1 mCi 167Tm-citrate were 7.08 rads and 1.28 rads, respectively.
D000818:Animals; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D011829:Radiation Dosage; D011868:Radioisotopes / Q000008:administration & dosage / Q000378:metabolism*; D051381:Rats; D013932:Thulium / Q000008:administration & dosage / Q000378:metabolism*; D013997:Time Factors; D014915:Whole-Body Counting
D011868:Radioisotopes; D013932:Thulium